• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index®

    12/13/24 8:00:00 PM ET
    $AXON
    $ILMN
    $MRNA
    $MSTR
    Ordnance And Accessories
    Industrials
    Medical Specialities
    Health Care
    Get the next $AXON alert in real time by email

    NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NASDAQ:NDX), which will become effective prior to market open on Monday, December 23, 2024.

    The following three companies will be added to the Index: Palantir Technologies Inc. (NASDAQ:PLTR), MicroStrategy Incorporated (NASDAQ:MSTR), and Axon Enterprise, Inc. (NASDAQ:AXON).

    The Nasdaq-100 Index® is composed of 100 of the largest non-financial companies1 listed on The Nasdaq Stock Market® and dates to January 1985 – nearly 40 years ago –when it was launched along with the Nasdaq Financial-100™ Index, which is comprised of 100 of the largest financial stocks on Nasdaq® These indexes act as benchmarks for financial products such as options, futures, and funds. The Nasdaq-100® is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    The Nasdaq-100 Index® is the basis of the Invesco QQQ Trust (NASDAQ:QQQ) which aims to provide investment results that, before expenses, correspond with the Nasdaq-100 Index® performance. In addition, options, futures and structured products based on the Nasdaq-100 Index® and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following three companies will be removed from the Index: Illumina, Inc. (NASDAQ:ILMN), Super Micro Computer, Inc. (NASDAQ:SMCI), and Moderna, Inc. (NASDAQ:MRNA).

    Information

    For information about the three companies to be added to the Nasdaq-100 Index®, please visit the following respective company websites:

    Palantir Technologies Inc. – https://www.palantir.com/

    MicroStrategy Incorporated – https://www.microstrategy.com/

    Axon Enterprise, Inc. – https://www.axon.com/

    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse. We continuously offer new opportunities for financial product sponsors across a wide spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index, and design solutions to financial organizations worldwide.

    _______________

    1 As outlined in the Nasdaq-100 Index® Methodology

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X, or at www.nasdaq.com. 

    The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The Nasdaq OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq's proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    - NDAQG - 

    Media Relations Contact Investor Relations Contact 
    Name: Jennifer Lawson

    Email: [email protected]

     Name: Index Client Services

    Email: [email protected]

     
        


    Primary Logo

    Get the next $AXON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AXON
    $ILMN
    $MRNA
    $MSTR

    CompanyDatePrice TargetRatingAnalyst
    Moderna Inc.
    $MRNA
    12/12/2025$30.00Hold
    Jefferies
    Nasdaq Inc.
    $NDAQ
    11/20/2025$110.00Equal-Weight → Overweight
    Morgan Stanley
    Strategy Inc
    $MSTR
    11/10/2025Sell → Neutral
    Monness Crespi & Hardt
    Super Micro Computer Inc.
    $SMCI
    11/6/2025Hold → Buy
    Argus
    Strategy Inc
    $MSTR
    10/15/2025$473.00Buy
    China Renaissance
    Axon Enterprise Inc.
    $AXON
    9/24/2025$893.00Overweight
    Piper Sandler
    Super Micro Computer Inc.
    $SMCI
    9/16/2025$46.00Mkt Perform
    Bernstein
    Illumina Inc.
    $ILMN
    8/12/2025$94.00Outperform → Neutral
    Daiwa Securities
    More analyst ratings

    $AXON
    $ILMN
    $MRNA
    $MSTR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance

    Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Scientists developed an antibody treatment that reawakens the immune system to attack pancreatic tumors by blocking sugar-coated disguises cancer cells use to evade detection[1]. Researchers also engineered an off-the-shelf immunotherapy that consistently slowed tumor growth across multiple preclinical pancreatic cancer models while maintaining potency in harsh tumor environments[2]. These advances position Oncolytics Biotech Inc. (NASDAQ:ONCY), Immuneering Corporation (NASDAQ:IMRX), Tango Therapeutics, Inc. (NASDAQ:TNGX), Moderna, Inc. (NASDAQ:MRNA), and Royalty Pharma

    12/12/25 10:47:00 AM ET
    $IMRX
    $MRNA
    $ONCY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    Azio AI Advances Sovereign AI Infrastructure Strategy, Supporting Philippines' National Investment Fund Modernization and Positioning for Long-Term Public-Sector Growth

    LOS ANGELES, Dec. 11, 2025 /PRNewswire/ -- Azio AI, the artificial intelligence compute and GPU infrastructure subsidiary of Azio, today announced its active participation in early-stage technical and infrastructure discussions supporting the Philippines' national initiative to modernize and restructure its sovereign investment platform, including the Maharlika Investment Fund (MIF) and Maharlika Investment Corporation (MIC). The engagement follows President Ferdinand Marcos Jr.'s 2024 directive to pause and comprehensively restructure the MIF, initiating a renewed 2024–2025 p

    12/11/25 5:06:00 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    Strategy Recognized as a Customers' Choice on Gartner Peer Insights™ through User Feedback for Fourth Consecutive Year

    Strategy is the only Analytics & Business Intelligence Platforms vendor to receive this distinction for four years in a row based on ratings from professional product users. Strategy Inc., formerly MicroStrategy, today announced that it is named a Customers' Choice in the 2025 Gartner Peer Insights™ ‘Voice of the Customer' report for Analytics & Business Intelligence (ABI) Platforms. Strategy was the only ABI vendor to receive this distinction for the fourth consecutive year. "We take customer success personally. It's at the heart of everything we stand for, and we believe that the results speak for themselves," said Saurabh Abhyankar, Executive Vice President and Chief Product Officer at

    12/11/25 10:00:00 AM ET
    $MSTR
    $STRC
    Computer Software: Prepackaged Software
    Technology
    Wholesale Distributors
    Industrials

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gottlieb Scott bought $61,065 worth of shares (500 units at $122.13), increasing direct ownership by 4% to 12,523 units (SEC Form 4)

    4 - ILLUMINA, INC. (0001110803) (Issuer)

    11/5/25 4:05:20 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Director Partovi Hadi bought $1,004,920 worth of shares (1,358 units at $740.00), increasing direct ownership by 0.57% to 237,938 units (SEC Form 4)

    4 - AXON ENTERPRISE, INC. (0001069183) (Issuer)

    8/15/25 4:36:59 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Director Briger Peter L Jr bought $19,800,000 worth of Series A Perpetual Stretch Preferred Stock (220,000 units at $90.00) (SEC Form 4)

    4 - MICROSTRATEGY Inc (0001050446) (Issuer)

    7/29/25 6:20:52 PM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hussain Abbas sold $13,910 worth of shares (504 units at $27.60), decreasing direct ownership by 25% to 1,515 units (SEC Form 4)

    4 - Moderna, Inc. (0001682852) (Issuer)

    12/11/25 4:16:32 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CHIEF EXECUTIVE OFFICER Smith Patrick W sold $5,519,164 worth of shares (10,000 units at $551.92), decreasing direct ownership by 0.32% to 3,110,997 units (SEC Form 4)

    4 - AXON ENTERPRISE, INC. (0001069183) (Issuer)

    12/9/25 6:44:20 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    PRESIDENT Isner Joshua sold $11,052,007 worth of shares (20,000 units at $552.60), decreasing direct ownership by 7% to 249,502 units (SEC Form 4)

    4 - AXON ENTERPRISE, INC. (0001069183) (Issuer)

    12/9/25 6:40:29 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies initiated coverage on Moderna with a new price target

    Jefferies initiated coverage of Moderna with a rating of Hold and set a new price target of $30.00

    12/12/25 8:52:58 AM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    NASDAQ upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded NASDAQ from Equal-Weight to Overweight and set a new price target of $110.00

    11/20/25 7:58:08 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Strategy Inc upgraded by Monness Crespi & Hardt

    Monness Crespi & Hardt upgraded Strategy Inc from Sell to Neutral

    11/10/25 8:37:33 AM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    SEC Filings

    View All

    SEC Form DEFA14A filed by Invesco QQQ Trust, Series 1

    DEFA14A - INVESCO QQQ TRUST, SERIES 1 (0001067839) (Filer)

    12/12/25 3:15:07 PM ET
    $QQQ

    SEC Form DEFA14A filed by Invesco QQQ Trust, Series 1

    DEFA14A - INVESCO QQQ TRUST, SERIES 1 (0001067839) (Filer)

    12/11/25 5:07:39 PM ET
    $QQQ

    SEC Form 144 filed by Moderna Inc.

    144 - Moderna, Inc. (0001682852) (Subject)

    12/11/25 4:30:43 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Financials

    Live finance-specific insights

    View All

    Walmart Debuts on Nasdaq, Marking Its First Day of Trading

    Company Rings in a New Era with Nasdaq Opening Bell Ceremony Walmart Inc. (NASDAQ:WMT) today announced it has completed the listing transfer of its common stock and bonds to Nasdaq and will begin trading, marking a new chapter in the company's 63-year history of growth, innovation, and long-term value creation for shareholders. This move follows an evaluation of several factors, including trading execution, brand alignment, and a shared focus on technology-driven innovation to support Walmart's position as the world's leading omnichannel retailer. As Walmart continues to define and lead the future of global retail, the company is confident that Nasdaq provides the optimal market platform

    12/9/25 7:00:00 AM ET
    $NDAQ
    $WMT
    Investment Bankers/Brokers/Service
    Finance
    Department/Specialty Retail Stores
    Consumer Discretionary

    Strategy Announces Establishment of $1.44 Billion USD Reserve and Updates FY 2025 Guidance

      Strategy Inc (NASDAQ:STRF, LuxSE: STRE)) today announced the establishment of a US dollar reserve ("USD Reserve") of $1.44 billion and updates to its assumptions underlying its previously issued forward guidance and bitcoin key performance indicator ("KPI") targets for the fiscal year ending December 31, 2025, which were published on October 30, 2025. Establishment of USD Reserve Strategy today announced that it has established a USD Reserve of $1.44 billion to support the payment of dividends on its preferred stock and interest on its outstanding indebtedness ("Dividends"). The USD Reserve was funded using proceeds from the sale of shares of class A common stock under Strategy's at-th

    12/1/25 8:00:00 AM ET
    $MSTR
    $STRC
    Computer Software: Prepackaged Software
    Technology
    Wholesale Distributors
    Industrials

    Palantir and FTAI Aviation Enter Strategic Partnership to Accelerate the Transformation of Aircraft Engine Maintenance, Repair and Exchange

    Palantir (NASDAQ:PLTR), a leading provider of AI software, and FTAI Aviation Ltd. (NASDAQ:FTAI), a global leader in aircraft engine maintenance, today announced a multi-year strategic partnership, which will allow FTAI to leverage Palantir's Artificial Intelligence Platform ("AIP") across FTAI's global maintenance footprint. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117324507/en/ Through this partnership, Palantir's AIP is helping FTAI transform productivity and reduce manufacturing costs by improving maintenance scheduling and inventory optimization across FTAI's operations worldwide. This includes transforming its inte

    11/17/25 6:59:00 AM ET
    $FTAI
    $PLTR
    Misc Corporate Leasing Services
    Industrials
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Illumina Inc.

    SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

    12/6/24 10:11:24 AM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Illumina Inc.

    SC 13G - ILLUMINA, INC. (0001110803) (Subject)

    12/5/24 7:27:01 PM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by MicroStrategy Incorporated

    SC 13G - MICROSTRATEGY Inc (0001050446) (Subject)

    11/14/24 6:24:12 PM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Leadership Updates

    Live Leadership Updates

    View All

    Lambda Appoints Heather Planishek as Chief Financial Officer

    Industry veteran brings deep financial and operational expertise as Lambda accelerates the deployment of AI factories to meet demand from hyperscalers, enterprises, and frontier labs building superintelligence Lambda, the Superintelligence Cloud, today announced the appointment of Heather Planishek as Chief Financial Officer. Planishek brings deep experience scaling high-growth technology companies and will lead Lambda's global finance organization as the company continues to expand its infrastructure footprint and operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251208888678/en/Lambda appoints Heather Planishek as Chi

    12/8/25 8:00:00 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    Surf Air Mobility Appoints Shawn Pelsinger to Board of Directors

    Mr. Pelsinger was formerly the Global Head of Corporate Development & Senior Counsel of Palantir Technologies. Surf Air Mobility Inc. (NYSE:SRFM) ("the Company", "Surf Air Mobility"), a leading regional air mobility platform, announced today the appointment of Shawn Pelsinger to the Company's Board of Directors, effective October 8, 2025. Mr. Pelsinger is currently Chief Legal Officer and Chief Administrative Officer of Acrisure, a global fintech provider of solutions across insurance, reinsurance, payroll, benefits, cybersecurity, and real estate services. Prior to joining Acrisure, Mr. Pelsinger was the Global Head of Corporate Development & Senior Counsel of Palantir Technologies (

    10/8/25 6:30:00 AM ET
    $PLTR
    $SRFM
    Computer Software: Prepackaged Software
    Technology
    Transportation Services
    Consumer Discretionary